Growth Metrics

Nuwellis (NUWE) Interest Expenses (2015 - 2025)

Nuwellis posted quarterly Interest Expenses of -$46000.0 for Q1 2025, up 89.02% year-on-year from -$24335.9 in Q1 2024, and up 89.02% on a QoQ basis from -$419000.0 in Q1 2024.

Nuwellis (NUWE) has 4 years of Interest Expenses data on file, last reported at -$46000.0 in Q1 2025.

  • For the quarter ending Q1 2025, Interest Expenses rose 89.02% year-over-year to -$46000.0; the trailing twelve-month figure through Dec 2025 stood at -$46000.0 (up 89.02% YoY), and the FY2025 full-year result was $6.4 million, up 3524.29% from the prior year.
  • Interest Expenses for Q1 2025 stood at -$46000.0, up from -$419000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at -$46000.0 in Q1 2025 and bottomed at -$419000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 174.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 148.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 181.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 90.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -97.17 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 96.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.10 Mn
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 -46,000.00
Mar 31, 2025 -46,000.00
Mar 31, 2024 -419,000.00
Mar 31, 2024 -419,000.00
Sep 30, 2016 68,000.00
Sep 30, 2016 68,000.00
Jun 30, 2016 1,000.00
Jun 30, 2016 1,000.00
Mar 31, 2016 229,000.00
Mar 31, 2016 229,000.00
Dec 31, 2015 245,000.00
Dec 31, 2015 245,000.00
Sep 30, 2015 280,000.00
Sep 30, 2015 280,000.00
Jun 30, 2015 155,000.00
Jun 30, 2015 155,000.00
Mar 31, 2015 63,000.00
Mar 31, 2015 63,000.00